BBH (VanEck Biotech ETF) Stock Analysis - Financials

VanEck Biotech ETF (BBH) is a publicly traded the market company. As of May 21, 2026, BBH trades at $144.42 with a market cap of $0 and a P/E ratio of 0.00. BBH moved -1.02% today. Year to date, BBH is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces BBH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are BBH's key financials?

BBH financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. BBH recently traded at $144.42. Market cap is $0. P/E ratio is 0.00. Revenue is $0.

BBH Key Metrics

Key financial metrics for BBH
MetricValue
Price$144.42
Market Cap$0
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$0.00
52-Week Low$0.00
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

BBH Analyst Consensus

BBH analyst coverage data. Average price target: $0.00.

Common questions about BBH

What are BBH's key financials?
BBH financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. BBH recently traded at $144.42. Market cap is $0. P/E ratio is 0.00. Revenue is $0.
Is BBH research on Rallies investment advice?
No. Rallies provides research, data, and educational context for BBH. It does not provide personalized investment advice.
BBH

BBH